Skip to main content
logo
BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
2.550
-0.050 (-1.92%)
Sep 24, 2026, 11:53 AM EDT - Market open

BioRestorative Therapies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-11.06-14.24-8.98-10.42-13.22-44.3
Depreciation & Amortization
0.210.210.190.170.120.09
Other Amortization
-----1.13
Stock-Based Compensation
1.613.332.817.7812.6123.11
Other Operating Activities
-3.15-1.39-2.28-4.48-5.4416.32
Change in Accounts Receivable
0.010.17-0.17-0-0.010.01
Change in Accounts Payable
0.040.840.290.020.12-0.07
Change in Unearned Revenue
-0.15-----
Change in Other Net Operating Assets
0.670.3-0.10.5-0.090.38
Operating Cash Flow
-11.82-10.79-8.23-6.43-5.91-3.33
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.08-0.12-0.11-0.17-0.27-0.03
Sale (Purchase) of Intangibles
-----0.18-
Investment in Securities
7.589.010.623.42-12.96-
Investing Cash Flow
7.58.90.513.25-13.4-0.03

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-----0.25
Total Debt Issued
-----0.25
Net Debt Issued (Repaid)
-----0.25
Issuance of Common Stock
7.013.148.122.35-21.07
Other Financing Activities
-0.81-0.28-0.74---
Financing Cash Flow
6.22.857.382.35-21.32

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
1.880.96-0.34-0.83-19.3117.96

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-11.9-10.91-8.34-6.6-6.18-3.36
Free Cash Flow Growth
------
Free Cash Flow Margin
-3324.57%-3031.70%-2078.94%-4527.61%-5157.20%-7305.58%
Free Cash Flow Per Share
-20.99-24.25-21.48-31.30-34.16-56.59
Levered Free Cash Flow
-9.71-6.2-3.11-5.086.155.7
Unlevered Free Cash Flow
-9.71-6.2-3.11-5.086.155.71

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0-----
Change in Working Capital
0.571.310.030.520.010.32
SEC Filings: 10-K · 10-Q